In this study, we showed that CD44-targeted NIR-PIT suppressed tumor growth and increased activation and tumor infiltration of CD8+ T cells resulting in a complete remission in approximately 15% of MOC2-luc tumor-bearing mice. The gene discussed is CD44; the disease is neoplasm.